Devapriya Appukuttan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Devapriya Appukuttan has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Sangeetha Subramanian
Department of Periodontics, SRM Dental College, Ramapuram, Chennai, Tamil Nadu, India
11 shared publications - P. S. G. Prakash
Department of Periodontics, SRM Dental College, Chennai, India
10 shared publications Sangeetha Subramanian
Department of Periodontics, SRM Dental College, Ramapuram, Chennai, Tamil Nadu, India
8 shared publications- Dhayanand John Victor
Department of Periodontics, SRM Dental College, Chennai, India
5 shared publications Anupama Tadepalli
SRM Dent Coll, Dept Periodont, Chennai 89, Tamil Nadu, India
4 shared publications- Abirami Thanigaimalai
Department of Periodontology and Oral Implantology, Tagore Dental College and Hospital, Chennai, India
3 shared publications
Latest Publications
- Open Access
- 1 May 2026
- Published by Wolters Kluwer Health in Journal of Interdisciplinary Dentistry
- Vol. 16 (2) , 281-295
Damage Signal or Regenerative Cue? Unraveling the Biphasic Paradox of High Mobility Group Box-1 in Periodontal Tissues – A Scoping Review
A BSTRACT: Background and Aims: High Mobility Group Box-1 (HMGB1) has emerged as a key mediator in inflammation and tissue remodeling. The goal of this scoping review is to comprehensively outline and evaluate the current literature evidence on HMGB1 in periodontitis, with a focus on its mechanistic role in disease pathogenesis and potential contribution to periodontal repair and regeneration. Guidelines and Sources of Evidence: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Extension for Scoping Reviews guidelines were followed. Literature search was done in PubMed/Medline, Scopus, Cochrane Library, Web of Science, Mendeley, and Google scholar using a blend of MeSH terms, keywords, and non-indexed terms related to “HMGB1,” “periodontitis,” “regeneration,” and “repair.” In addition, a thorough search of bibliographies and gray literature was conducted to ensure comprehensive coverage until August 2025. Results: In total, 362 records were collected initially, duplicates were eliminated, thereafter the titles and abstracts were appraised for relevance, and finally 39 studies were eligible and were retained for detailed analysis. The articles were categorized into those examining HMGB1 as an inflammatory marker ( n = 20), a reparative or regenerative marker ( n = 8), and as a component of inflammatory cytokines or damage-associated molecular patterns (DAMPs) repertoire within periodontal tissues ( n = 11). Conclusions: HMGB1 acts as a DAMP, pro-inflammatory, and osteoclastogenic cytokine, inducing and amplifying inflammation in periodontitis. However, data substantiating its definitive role in periodontal regeneration and repair remain limited and inconclusive. Furthermore, limited studies have elucidated the specific molecular pathways underlying HMGB1 receptor binding, activation pathways, and downstream signaling, highlighting the need for future investigations in this largely unexplored domain.
- 1 May 2026
- Published by Wolters Kluwer Health in Journal of Interdisciplinary Dentistry
- Vol. 16 (2) , 281-295
Open AccessDamage Signal or Regenerative Cue? Unraveling the Biphasic Paradox of High Mobility Group Box-1 in Periodontal Tissues – A Scoping Review
A BSTRACT: Background and Aims: High Mobility Group Box-1 (HMGB1) has emerged as a key mediator in inflammation and tissue remodeling. The goal of this scoping review is to comprehensively outline and evaluate the current literature evidence on HMGB1 in periodontitis, with a focus on its mechanistic role in disease pathogenesis and potential contribution to periodontal repair and regeneration. Guidelines and Sources of Evidence: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Extension for Scoping Reviews guidelines were followed. Literature search was done in PubMed/Medline, Scopus, Cochrane Library, Web of Science, Mendeley, and Google scholar using a blend of MeSH terms, keywords, and non-indexed terms related to “HMGB1,” “periodontitis,” “regeneration,” and “repair.” In addition, a thorough search of bibliographies and gray literature was conducted to ensure comprehensive coverage until August 2025. Results: In total, 362 records were collected initially, duplicates were eliminated, thereafter the titles and abstracts were appraised for relevance, and finally 39 studies were eligible and were retained for detailed analysis. The articles were categorized into those examining HMGB1 as an inflammatory marker ( n = 20), a reparative or regenerative marker ( n = 8), and as a component of inflammatory cytokines or damage-associated molecular patterns (DAMPs) repertoire within periodontal tissues ( n = 11). Conclusions: HMGB1 acts as a DAMP, pro-inflammatory, and osteoclastogenic cytokine, inducing and amplifying inflammation in periodontitis. However, data substantiating its definitive role in periodontal regeneration and repair remain limited and inconclusive. Furthermore, limited studies have elucidated the specific molecular pathways underlying HMGB1 receptor binding, activation pathways, and downstream signaling, highlighting the need for future investigations in this largely unexplored domain.
- 29 November 2025
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 29 (12) , 591
Comparative evaluation of ferroptosis markers NCOA4, ACSL4, and Nrf2 in periodontitis with and without type 2 diabetes mellitus: a case-control study
Aim The Nuclear Receptor Coactivator 4 (NCOA4)-mediated ferritinophagy and the Acyl-CoA synthetase long-chain family member 4 (ACSL4)-mediated lipid peroxidation promote ferroptosis. Nuclear factor erythroid-2 related factor-2 (Nrf2), a transcription factor, controls antioxidants, detoxifying enzymes, and ferroptosis. The concerted activity of NCOA4, ACSL4, and Nrf2 in periodontitis associated with or without T2DM needs exploration. Materials and methods Forty-two patients were recruited and categorized into 3 groups: Group I: systemically and periodontally healthy (PH, n = 14); Group II: Stage III/IV Periodontitis (PD, n = 14); Group III: Stage III/IV Periodontitis with uncontrolled Type 2 Diabetes mellitus (T2DM + DM, n = 14). The site-specific periodontal clinical parameters were recorded. Gingival tissue biopsies were evaluated for gene expression of NCOA4, Nrf2, and ACSL4 by real time -PCR. Results In groups II and III, NCOA4 expression increased by 10.07 ± 9.15 and 9.40 ± 6.29-fold, respectively, whereas ACSL4 expression increased by 3.23 ± 2.53 and 2.03 ± 2.22-fold, respectively, compared to group I (P < 0.05). Nrf2 expression decreased in groups II (0.36 ± 0.39) and III (0.83 ± 0.89) compared to group I, with the least expression in group II. In the total sample analysis, NCOA4 FC and Nrf2 CT showed a significant positive correlation with all clinical parameters and with each other (P < 0.05). There was a significant positive correlation (P < 0.05) between NCOA4 FC and ACSL4 CT (P < 0.05). In group II, NCOA4 CT had significant positive and negative correlations with Nrf2 FC and ACSL4 FC values, respectively (P < 0.05). The diagnostic accuracy of NCOA4 and Nrf2 in differentiating between periodontal health and periodontitis was 89% (AUC = 0.96) and 71% (AUC = 0.60), respectively. Likewise, NCOA4 and Nrf2 demonstrated diagnostic accuracy of 67.8% (AUC = 0.73) and 78.5% (AUC = 0.85) in differentiating between diabetic periodontitis and periodontal health, respectively. Conclusions Ferroptosis in the progression of periodontitis and diabetes-associated periodontitis may be linked to dysregulated expressions of the NCOA4, ACSL4, and Nrf2 genes. However, additional investigation is required to fully comprehend the findings.
- 29 November 2025
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 29 (12) , 591
Comparative evaluation of ferroptosis markers NCOA4, ACSL4, and Nrf2 in periodontitis with and without type 2 diabetes mellitus: a case-control study
Aim The Nuclear Receptor Coactivator 4 (NCOA4)-mediated ferritinophagy and the Acyl-CoA synthetase long-chain family member 4 (ACSL4)-mediated lipid peroxidation promote ferroptosis. Nuclear factor erythroid-2 related factor-2 (Nrf2), a transcription factor, controls antioxidants, detoxifying enzymes, and ferroptosis. The concerted activity of NCOA4, ACSL4, and Nrf2 in periodontitis associated with or without T2DM needs exploration. Materials and methods Forty-two patients were recruited and categorized into 3 groups: Group I: systemically and periodontally healthy (PH, n = 14); Group II: Stage III/IV Periodontitis (PD, n = 14); Group III: Stage III/IV Periodontitis with uncontrolled Type 2 Diabetes mellitus (T2DM + DM, n = 14). The site-specific periodontal clinical parameters were recorded. Gingival tissue biopsies were evaluated for gene expression of NCOA4, Nrf2, and ACSL4 by real time -PCR. Results In groups II and III, NCOA4 expression increased by 10.07 ± 9.15 and 9.40 ± 6.29-fold, respectively, whereas ACSL4 expression increased by 3.23 ± 2.53 and 2.03 ± 2.22-fold, respectively, compared to group I (P < 0.05). Nrf2 expression decreased in groups II (0.36 ± 0.39) and III (0.83 ± 0.89) compared to group I, with the least expression in group II. In the total sample analysis, NCOA4 FC and Nrf2 CT showed a significant positive correlation with all clinical parameters and with each other (P < 0.05). There was a significant positive correlation (P < 0.05) between NCOA4 FC and ACSL4 CT (P < 0.05). In group II, NCOA4 CT had significant positive and negative correlations with Nrf2 FC and ACSL4 FC values, respectively (P < 0.05). The diagnostic accuracy of NCOA4 and Nrf2 in differentiating between periodontal health and periodontitis was 89% (AUC = 0.96) and 71% (AUC = 0.60), respectively. Likewise, NCOA4 and Nrf2 demonstrated diagnostic accuracy of 67.8% (AUC = 0.73) and 78.5% (AUC = 0.85) in differentiating between diabetic periodontitis and periodontal health, respectively. Conclusions Ferroptosis in the progression of periodontitis and diabetes-associated periodontitis may be linked to dysregulated expressions of the NCOA4, ACSL4, and Nrf2 genes. However, additional investigation is required to fully comprehend the findings.
- 12 August 2025
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 29 (9) , 1-8
Clinical, radiographic and molecular efficacy of LLLT along with minimally invasive flaps in regeneration of periodontal intrabony defects: a randomized controlled clinical trial
Aim The current study evaluates the effectiveness of low level laser therapy (LLLT) in intra-bony defect regeneration, by comparing the clinical, radiographic and molecular parameters between periodontitis patients with intra-bony defects treated with simplified papilla preservation flap(SPPF) alone and SPPF with adjunctive use of LLLT. Methodology The current study is a randomized controlled clinical trial involving 64 sites, 32 sites treated with SPPF- control group and 32 sites treated with SPPF and adjunctive use of LLLT(SPPF + LLLT)– test group. Clinical parameters were evaluated at baseline, 6 months and 1 year post surgery. Radiographic defect depths were evaluated at baseline and 1 year post surgery. Molecular parameters– RUNX2, BMP-2, osteopontin and COL-1 are evaluated at 3, 7 and 14 days. The results were statistically analysed. Results There was a statistically significant reduction in clinical parameters and radiographic defect depth seen in test group at the 6 months and one year post surgery when compared with control group (P < 0.05). In addition, the total number of sites with probing pocket depth more than 4 mm has reduced significantly in test group when compared to control group at 6 months and one year. RUNX2, BMP-2 and COL − 1 were significantly elevated in test group. Conclusion The current study reports a significant improvement of clinical, radiographic and molecular parameters of intra-bony defect sites in periodontitis patients treated with SPPF + LLLT when compared to SPPF alone.
- 12 August 2025
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 29 (9) , 1-8
Clinical, radiographic and molecular efficacy of LLLT along with minimally invasive flaps in regeneration of periodontal intrabony defects: a randomized controlled clinical trial
Aim The current study evaluates the effectiveness of low level laser therapy (LLLT) in intra-bony defect regeneration, by comparing the clinical, radiographic and molecular parameters between periodontitis patients with intra-bony defects treated with simplified papilla preservation flap(SPPF) alone and SPPF with adjunctive use of LLLT. Methodology The current study is a randomized controlled clinical trial involving 64 sites, 32 sites treated with SPPF- control group and 32 sites treated with SPPF and adjunctive use of LLLT(SPPF + LLLT)– test group. Clinical parameters were evaluated at baseline, 6 months and 1 year post surgery. Radiographic defect depths were evaluated at baseline and 1 year post surgery. Molecular parameters– RUNX2, BMP-2, osteopontin and COL-1 are evaluated at 3, 7 and 14 days. The results were statistically analysed. Results There was a statistically significant reduction in clinical parameters and radiographic defect depth seen in test group at the 6 months and one year post surgery when compared with control group (P < 0.05). In addition, the total number of sites with probing pocket depth more than 4 mm has reduced significantly in test group when compared to control group at 6 months and one year. RUNX2, BMP-2 and COL − 1 were significantly elevated in test group. Conclusion The current study reports a significant improvement of clinical, radiographic and molecular parameters of intra-bony defect sites in periodontitis patients treated with SPPF + LLLT when compared to SPPF alone.
- Open Access
- 16 July 2025
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
- Vol. 17 (2) , 292-298
Association of NAT2 341C/T Gene Polymorphism and Risk of Periodontitis in Smokers: A Case-control Study
Background: Periodontitis, an inflammatory disease, is caused by oral biofilm, and several risk factors propagate it. Smoking is a significant risk factor that increases the severity of the disease. Arylamine N -acetyltransferase 2 (NAT2) enzyme present in the liver detoxify the smoke contents and renders it non-toxic to the tissues. The gene polymorphism of the NAT2 enzyme has been associated with various inflammatory diseases, including cancer. Objectives: The current study aimed to investigate the association between NAT2 gene polymorphism at loci 341C/T in smokers with periodontitis in the ethnic Tamil population of South India. Materials and Methods: The study had three groups, comprising smokers with healthy periodontium as the control group, smokers with periodontitis as the test group 1, and non-smokers with periodontitis as the test group 2. A total of 150 subjects were recruited, with 50 participants in each group. Periodontal parameters like clinical attachment loss (CAL), probing pocket depth (PPD), plaque index (PlI), and modified sulcus bleeding index (mSBI) were evaluated. Blood samples from the participants were collected and subjected to deoxyribonucleic acid (DNA) extraction, polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay to evaluate NAT2 gene polymorphism at the 341C/T site. Results: The distribution of heterozygous genotype CT was slightly higher in the periodontitis group comprising smokers (62%) compared to other study groups. However, it was not statistically significant. The test groups 1 and 2 demonstrated an odds ratio of around 1.78 and 1.6, respectively, for the heterozygous genotype. Conclusion: It can be concluded from the study that NAT2 gene polymorphism at the 341C/T site was not associated with periodontitis, irrespective of the smoking habit in the ethnic Tamil South Indian population.
- 16 July 2025
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
- Vol. 17 (2) , 292-298
Open AccessAssociation of NAT2 341C/T Gene Polymorphism and Risk of Periodontitis in Smokers: A Case-control Study
Background: Periodontitis, an inflammatory disease, is caused by oral biofilm, and several risk factors propagate it. Smoking is a significant risk factor that increases the severity of the disease. Arylamine N -acetyltransferase 2 (NAT2) enzyme present in the liver detoxify the smoke contents and renders it non-toxic to the tissues. The gene polymorphism of the NAT2 enzyme has been associated with various inflammatory diseases, including cancer. Objectives: The current study aimed to investigate the association between NAT2 gene polymorphism at loci 341C/T in smokers with periodontitis in the ethnic Tamil population of South India. Materials and Methods: The study had three groups, comprising smokers with healthy periodontium as the control group, smokers with periodontitis as the test group 1, and non-smokers with periodontitis as the test group 2. A total of 150 subjects were recruited, with 50 participants in each group. Periodontal parameters like clinical attachment loss (CAL), probing pocket depth (PPD), plaque index (PlI), and modified sulcus bleeding index (mSBI) were evaluated. Blood samples from the participants were collected and subjected to deoxyribonucleic acid (DNA) extraction, polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay to evaluate NAT2 gene polymorphism at the 341C/T site. Results: The distribution of heterozygous genotype CT was slightly higher in the periodontitis group comprising smokers (62%) compared to other study groups. However, it was not statistically significant. The test groups 1 and 2 demonstrated an odds ratio of around 1.78 and 1.6, respectively, for the heterozygous genotype. Conclusion: It can be concluded from the study that NAT2 gene polymorphism at the 341C/T site was not associated with periodontitis, irrespective of the smoking habit in the ethnic Tamil South Indian population.
- Open Access
- 24 May 2025
- Published by Maad Rayan Publishing Company in Journal of lasers in medical sciences
- Vol. 16, e13
Evaluation of LLLT Along With Minimally Invasive Flaps in Regeneration of Periodontal Intrabony Defects: A Randomized Controlled Clinical Trial
Introduction: The current study aims at evaluating the effectiveness of low level laser therapy (LLLT) in intra-bony defect regeneration by comparing the clinical parameters between periodontitis patients with intra-bony defects treated with simplified papilla preservation flap (SPPF) alone and SPPF with the adjunctive use of LLLT. Methods: The current study is a randomized controlled clinical trial involving 64 patients/sites, 32 sites treated with SPPF – control group and 32 sites treated with SPPF and adjunctive use of LLLT (SPPF+LLLT) – test group. Clinical parameters such as probing pocket depth (PPD), clinical attachment level (CAL), position of gingival margin (PGM), radiographic intra-bony defect depth (R-IBD), full mouth plaque score (FMPS), and full mouth bleeding score (FMBS) were evaluated at baseline, 6 months, and one year post-surgery. Radiographic defect depths were assessed at baseline and one year post-surgery. The results were statistically analyzed. Results: There was a statistically significant reduction in the PPD, CAL, PGM, and radiographic defect depth in the test group at the 6 months and one year post-surgery when compared with the control group (P<0.05). In addition, the total number of sites with PPD more than 4 mm was reduced significantly in the test group when compared to the control group at 6 months and one year. Conclusion: The current study reports a significant improvement in PPD and radiographic intrabony defect fill in periodontitis patients treated with adjunctive LLLT supplementing SPPF. The article evaluates the adjunctive usage of LLLT in periodontal regeneration. The results reiterate the synergistic role of LLLT with periodontal surgical therapy for accelerated regenerative outcomes.
- 24 May 2025
- Published by Maad Rayan Publishing Company in Journal of lasers in medical sciences
- Vol. 16, e13
Open AccessEvaluation of LLLT Along With Minimally Invasive Flaps in Regeneration of Periodontal Intrabony Defects: A Randomized Controlled Clinical Trial
Introduction: The current study aims at evaluating the effectiveness of low level laser therapy (LLLT) in intra-bony defect regeneration by comparing the clinical parameters between periodontitis patients with intra-bony defects treated with simplified papilla preservation flap (SPPF) alone and SPPF with the adjunctive use of LLLT. Methods: The current study is a randomized controlled clinical trial involving 64 patients/sites, 32 sites treated with SPPF – control group and 32 sites treated with SPPF and adjunctive use of LLLT (SPPF+LLLT) – test group. Clinical parameters such as probing pocket depth (PPD), clinical attachment level (CAL), position of gingival margin (PGM), radiographic intra-bony defect depth (R-IBD), full mouth plaque score (FMPS), and full mouth bleeding score (FMBS) were evaluated at baseline, 6 months, and one year post-surgery. Radiographic defect depths were assessed at baseline and one year post-surgery. The results were statistically analyzed. Results: There was a statistically significant reduction in the PPD, CAL, PGM, and radiographic defect depth in the test group at the 6 months and one year post-surgery when compared with the control group (P<0.05). In addition, the total number of sites with PPD more than 4 mm was reduced significantly in the test group when compared to the control group at 6 months and one year. Conclusion: The current study reports a significant improvement in PPD and radiographic intrabony defect fill in periodontitis patients treated with adjunctive LLLT supplementing SPPF. The article evaluates the adjunctive usage of LLLT in periodontal regeneration. The results reiterate the synergistic role of LLLT with periodontal surgical therapy for accelerated regenerative outcomes.
- 21 January 2025
- Published by SAGE Publications in Journal of Advanced Oral Research
- Vol. 16 (1) , 62-73
High Mobility Group Box-1 (HMGB1)/microRNA-155 Axis in the Pathogenesis of Type 2 Diabetes Mellitus Associated Periodontitis: A Case Control Study
Aim: To evaluate the role of the high mobility group box-1 (HMGB1)/miR-155 axis in the pathogenesis of stage III/IV periodontitis with and without type 2 diabetes mellitus (T2DM). Materials and Methods: A total of 48 patients were assigned into four groups (12 per group): group 1: systemically and periodontally healthy (PH), group 2: systemically healthy with stage III/IV periodontitis (PD), group 3: PH with T2DM (PH + T2DM), group 4: stage III/IV periodontitis with T2DM, HbA1c ≤ 7 (PD + T2DM). Site-specific plaque index (SS-PI), gingival index (SS-GI), mean probing pocket depth (M-PPD) and clinical attachment loss (M-CAL) were recorded. Gingival tissue samples were analysed for HMGB1 and miR-155 gene expression by real-time polymerase chain reaction. Results: The miR-155 fold change (FC) increased by 10.29, 8.1 and 5.6 times in groups 4, 3 and 2, respectively. Intergroup comparison of miR-155 FC showed a significant difference between the groups ( p < .05). HMGB1 FC increased by 6.5, 5.9 and 5.23 times in groups 4, 2 and 3, respectively, with no significant difference ( p > .05). miR-155 FC is positively and significantly correlated with M-PPD (group 1, 2 and total sample), site-specific plaque score (SS-PS) (group 4) and SS-GI (total sample). miR-155 could discriminate periodontal health from T2DM + PD based on area under the curve 0.82 ( p < .05) with 83.3% sensitivity, 75% specificity, 76.9% positive and 81.8% negative predictive value and 79.2% diagnostic accuracy. Conclusion: miR-155 is significantly upregulated in the diseased periodontium both in the presence and absence of T2DM. Further, miR-155 could be a potential diagnostic biomarker for diabetes-associated PD. However, the significance of HMGB1 and the HMGB1-miR155 axis in the aetiology of diabetes-associated PD is still unclear and warrants additional investigation.
- 21 January 2025
- Published by SAGE Publications in Journal of Advanced Oral Research
- Vol. 16 (1) , 62-73
High Mobility Group Box-1 (HMGB1)/microRNA-155 Axis in the Pathogenesis of Type 2 Diabetes Mellitus Associated Periodontitis: A Case Control Study
Aim: To evaluate the role of the high mobility group box-1 (HMGB1)/miR-155 axis in the pathogenesis of stage III/IV periodontitis with and without type 2 diabetes mellitus (T2DM). Materials and Methods: A total of 48 patients were assigned into four groups (12 per group): group 1: systemically and periodontally healthy (PH), group 2: systemically healthy with stage III/IV periodontitis (PD), group 3: PH with T2DM (PH + T2DM), group 4: stage III/IV periodontitis with T2DM, HbA1c ≤ 7 (PD + T2DM). Site-specific plaque index (SS-PI), gingival index (SS-GI), mean probing pocket depth (M-PPD) and clinical attachment loss (M-CAL) were recorded. Gingival tissue samples were analysed for HMGB1 and miR-155 gene expression by real-time polymerase chain reaction. Results: The miR-155 fold change (FC) increased by 10.29, 8.1 and 5.6 times in groups 4, 3 and 2, respectively. Intergroup comparison of miR-155 FC showed a significant difference between the groups ( p < .05). HMGB1 FC increased by 6.5, 5.9 and 5.23 times in groups 4, 2 and 3, respectively, with no significant difference ( p > .05). miR-155 FC is positively and significantly correlated with M-PPD (group 1, 2 and total sample), site-specific plaque score (SS-PS) (group 4) and SS-GI (total sample). miR-155 could discriminate periodontal health from T2DM + PD based on area under the curve 0.82 ( p < .05) with 83.3% sensitivity, 75% specificity, 76.9% positive and 81.8% negative predictive value and 79.2% diagnostic accuracy. Conclusion: miR-155 is significantly upregulated in the diseased periodontium both in the presence and absence of T2DM. Further, miR-155 could be a potential diagnostic biomarker for diabetes-associated PD. However, the significance of HMGB1 and the HMGB1-miR155 axis in the aetiology of diabetes-associated PD is still unclear and warrants additional investigation.
- 12 December 2024
- Published by Elsevier in Human Immunology
- Vol. 86 (1) , 111214
Role of miRNA-155 in macrophage polarisation in stage III/IV periodontitis with type II diabetes mellitus: An analytical case-control study
- 12 December 2024
- Published by Elsevier in Human Immunology
- Vol. 86 (1) , 111214
Role of miRNA-155 in macrophage polarisation in stage III/IV periodontitis with type II diabetes mellitus: An analytical case-control study
- Open Access
- 1 November 2023
- Published by Medknow in Journal of International Oral Health
- Vol. 15 (6) , 565-573
Solitary extramedullary plasmacytoma of the gingiva—A case report with literature review
Extramedullary solitary plasmacytoma (EMP) is a plasma cell neoplasm involving the soft tissues without the involvement of the bone marrow. In this case report, we present an isolated soft tissue growth on the lingual gingiva of the left mandibular canine-premolar region diagnosed as EMP based on clinical, histological, and laboratory results. Orthopantomogram and occlusal radiographs showed no osteolytic lesions. Hematoxylin and Eosin staining showed sheets of inflammatory cells, predominantly atypical plasma cells with varying degrees of differentiation showing features of pleomorphism, and multinucleated giant cells with intervening collagen fibers. Positive immunoreactivity for CD56, CD138, and kappa light chain restriction were observed. Serum protein electrophoresis demonstrated an increase in IgA levels and immunofixation electrophoresis confirmed the presence of the M band in the IgG and kappa lanes, indicating monoclonal gammopathies. Based on the above findings, the case was diagnosed as EMP; the consultant pathologist, however, recommended excluding multiple myeloma.
- 1 November 2023
- Published by Medknow in Journal of International Oral Health
- Vol. 15 (6) , 565-573
Open AccessSolitary extramedullary plasmacytoma of the gingiva—A case report with literature review
Extramedullary solitary plasmacytoma (EMP) is a plasma cell neoplasm involving the soft tissues without the involvement of the bone marrow. In this case report, we present an isolated soft tissue growth on the lingual gingiva of the left mandibular canine-premolar region diagnosed as EMP based on clinical, histological, and laboratory results. Orthopantomogram and occlusal radiographs showed no osteolytic lesions. Hematoxylin and Eosin staining showed sheets of inflammatory cells, predominantly atypical plasma cells with varying degrees of differentiation showing features of pleomorphism, and multinucleated giant cells with intervening collagen fibers. Positive immunoreactivity for CD56, CD138, and kappa light chain restriction were observed. Serum protein electrophoresis demonstrated an increase in IgA levels and immunofixation electrophoresis confirmed the presence of the M band in the IgG and kappa lanes, indicating monoclonal gammopathies. Based on the above findings, the case was diagnosed as EMP; the consultant pathologist, however, recommended excluding multiple myeloma.